Log In
Print
BCIQ
Print
Print this Print this
 

crenezumab (MABT5102A, RG7412)

Also known as: Anti-Abeta

  Manage Alerts
Collapse Summary General Information
Company AC Immune S.A.
DescriptionHumanized mAb against beta amyloid
Molecular Target Beta amyloid
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase II
IndicationAlzheimer's disease (AD)
Partner

Genentech Inc.; Roche
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today